Show simple item record

dc.contributor.authorALPTEKİN, KÖKSAL
dc.contributor.authorUcok, Alp
dc.contributor.authorvan Os, Jim
dc.contributor.authorSAKA, MERAM CAN
dc.contributor.authorGÜLLÜ, SEVİM
dc.contributor.authorATBAŞOĞLU, EŞREF CEM
dc.contributor.authorGumus-Akay, Guvem
dc.contributor.authorGuloksuz, Sinan
dc.date.accessioned2021-03-05T20:22:39Z
dc.date.available2021-03-05T20:22:39Z
dc.date.issued2018
dc.identifier.citationATBAŞOĞLU E. C. , Gumus-Akay G., Guloksuz S., SAKA M. C. , Ucok A., ALPTEKİN K., GÜLLÜ S., van Os J., "Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia", PSYCHOPHARMACOLOGY, cilt.235, ss.1029-1039, 2018
dc.identifier.issn0033-3158
dc.identifier.othervv_1032021
dc.identifier.otherav_d3dd64a5-5788-4303-a8f6-84e835f923ea
dc.identifier.urihttp://hdl.handle.net/20.500.12627/139844
dc.identifier.urihttps://doi.org/10.1007/s00213-017-4818-z
dc.description.abstractType 2 diabetes (T2D) is more frequent in schizophrenia (Sz) than in the general population. This association is partly accounted for by shared susceptibility genetic variants.
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPsikiyatri
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSinirbilim ve Davranış
dc.subjectNEUROSCIENCES
dc.titleHigher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia
dc.typeMakale
dc.relation.journalPSYCHOPHARMACOLOGY
dc.contributor.departmentAnkara Üniversitesi , ,
dc.identifier.volume235
dc.identifier.issue4
dc.identifier.startpage1029
dc.identifier.endpage1039
dc.contributor.firstauthorID252644


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record